Pinned Tweet
Planned a tweet, but had too much to say on $EVC.
ATS growth went from +123% to +230% (4Q25 to 2Q26) and EBIT >tripled, yet the EBIT multiple fell from 21x to ~5x (ex media+spectrum) w/ px up just 53%. New CMO, 2 new directors and a strong ranking add to the case.
Link in bio!
I think $TERNOR should have made a bigger number out of this, but they reclassified changes in WC starting in 1Q26. On the old CF layout it looks like there’s no WC release in Q4, but restated it’s +126m. The APM table (using balance sheet NWC) shows +124.5m too
Replying to @financeamir @BuffDawgg
WC release was +6m in Q4 2025 and -42m in Q4 2024. Can’t really see the positive seasonality here to be fair 😁
$TERNOR Q3: rev SEK 931m (+17% Y/Y), adj. EBITA SEK 32m (3.4% margin, +80bps). On track for FY26 3.9% margin target as Q4 was 49-51% of adj. EBITA in ‘24-25. Backlog SEK 7.2b (+22%), order intake SEK 337m (+61%), and CMD targets reiterated. Stock still at ~5x my FY28e FCFF
$CEDER +20% in a month as Kristersson becomes the favorite for PM. Direct RE ownership diversifies political risk, K3 to IFRS should improve screening, and a main listing opens up institutional capital. Based on the guided FY27 floor, you’re paying sub 6x EBITA here.
TheOracleOfOslo retweeted
5 more I read and liked, all credited inside the issue.
🔹 Midwich Group ($MIDW.L): specialist AV distributor with a dominant UK position, priced at a cyclical trough with recent signs of organic growth. raut capital
🔹 DY Power ($210540.KS): Korean hydraulic cylinder maker with net cash at 4.2x earnings, waiting on Value-Up reforms to lift its payout from 25% toward 60%. Uncrowded Value
🔹 Entravision ($EVC): a fast-growing ad-tech arm, Smadex, inside a company the market still reads through its legacy media. @BuffDawgg
🔹 Nuvectis Pharma ($NVCT): 2 near-term catalysts, an FDA path for NXP100 and Phase 1b data for NXP200, while partner Haisco funds the large trials. Truffle Pigs
🔹 Jewett-Cameron ($JCTC): liquidation would return $6.75 a share against $2.72, through a new board elected to force it. Terry Schumacher
All 9 authors did the research and I only chose between them, so follow them ahead of me.
Link in the comments.
Using a/r and exit rate from the HK account as a proxy for spend (assuming unchanged payment terms), there was a pick-up at quarter-end (+10% vs. Q2), suggesting spend has either stabilized or is ramping. Also indicative of Smadex’s clients adjusting, rather than pulling spend.
$EVC Q3 print: ATS rev +133% yy (-3% seq) vs. guided floor of > 100% yy. Take-rate rose to 39.4% (38.8%), while the core book grew 68% yy and 19% seq. Concentration risk fell w/ the HK customer now = 30% of group rev. #2 whale now = 8% (+59% seq), and EVC sold 1 station for $30m.
15
1,123
$EVC Q3 print: ATS rev +133% yy (-3% seq) vs. guided floor of > 100% yy. Take-rate rose to 39.4% (38.8%), while the core book grew 68% yy and 19% seq. Concentration risk fell w/ the HK customer now = 30% of group rev. #2 whale now = 8% (+59% seq), and EVC sold 1 station for $30m.
Planned a tweet, but had too much to say on $EVC.
ATS growth went from +123% to +230% (4Q25 to 2Q26) and EBIT >tripled, yet the EBIT multiple fell from 21x to ~5x (ex media+spectrum) w/ px up just 53%. New CMO, 2 new directors and a strong ranking add to the case.
Link in bio!
ATS EBIT+margin fell q/q on sales, engineering and adops hiring plus a multi-cloud migration. Media’s Q3 was very weak (though political spend is mostly Q4), but the silver lining is that mgmt is exploring options for the TV stations, pointing to a partial media/ATS separation.
1
1
684
TheOracleOfOslo retweeted
Small Cap stocks don’t even try to go up anymore. They just look at you like this.
$EVC's TelevisaUnivision affiliation got a 3-month extension, w/ quarterly rolling. It provides some visibility, but reads like a stopgap while talks continue.
Maybe a bit far-fetched, but could TelevisaUnivision be eyeing EVC's TV stations now that the 39% cap is being lifted?
Small contract, but it ends a months-long silence. $HAV notes that scopes like this typically generate NOK 40-60m in revenue, and that engineering and procurement kick off this year.
1
17
1,299
On EVC, assuming the core book keeps compounding, a 64% drop in HK spend and 12/4x multiples = >3x. $HAV flipped in the q on weak order intake, but the asymmetric setup, promising mgmt commentary re the strategic review and better 2027 visibility by Q3 reinforce my conviction
8
972
$EVC: mgmt guided for >100% Y/Y in Q3 and Q4, but the stock got beaten up on concentration and the guide down. Meanwhile ATS core (ex. HK whale) grew 81% Y/Y. I dig into whether Smadex is any good, the CTV inflection, an updated valuation and everything in between. Link in bio!
$HAV: SEAM's 2025 numbers are out. Hanwha paid ~20x FY25 EBIT (NOK 102m) for 38% rev growth/10.8% margin vs. 62% at 10.4% margin for NES. NES growth has accelerated this year but applying the same multiple to its '25 EBIT = 165% upside w/ 0 value to RemainCo. On FY26e, it's a 4x
$HAV Q2: rev +38% y/y, EBITDA NOK 17.3m (6.5% margin vs. 2.1% in 2Q5). VERY disappointing order intake at NOK 35m (0.13x book-to-bill), and the backlog dropped further to NOK 826m. But w/ NOK 237m of net cash, you're paying sub 4x EBITDA run rate for a biz mgmt expects to inflect
TheOracleOfOslo retweeted
This Starz Entertainment $STRZ pitch from @BuffDawgg is up over 100% in 1y
I'll be publishing an update on $EVC soon, but Dylan's letter is a must-read. He covers the 3 assets (ATS, Media and spectrum) in great detail, Smadex's differentiation and flywheel, CTV, Starlink/MNOs driving spectrum value, and more. Highly recommend!
24
3,452










































